$3.65
▲ +$0.03
(+0.83%)
Vol 247K
8
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$1.5B
P/E
21.6
Margin
12.1%
Beta
0.12
52W
$4–$14
Wall Street Consensus
12 analysts · Apr 20263
Strong Buy
6
Buy
2
Hold
1
Sell
0
Strong Sell
75.0%
Buy Rating
Price Chart
Earnings
Beat rate: 60.0%
Next Report
May 06, 2026
EPS Estimate: $0.03
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $0.03 | — | — |
| Dec 2025 | $-0.05 | $-0.37 | $-0.32 |
| Sep 2025 | $-0.02 | $-0.05 | $-0.03 |
| Jun 2025 | $-0.03 | $0.14 | +$0.17 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… |
|---|---|---|---|---|---|
| Revenue | $102.9M | $151.2M | $132.8M | $173.2M | $113.7M |
| Net Income | -$11.4M | -$67.0M | $109.7M | $32.0M | -$5.3M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | — | — | — | — | — |
| P/E (TTM) | 43.68 | 25.70 | 39.01 | 36.44 | 21.91 | 21.55 |
| Net Margin | 18.5% | 16.4% | 11.3% | 11.3% | 11.3% | 12.1% |
| Gross Margin | 57.4% | 60.7% | 53.9% | 53.9% | 53.9% | 55.6% |
| D/E Ratio | — | — | — | — | — | — |
| Current Ratio | 1.82 | 1.73 | 1.82 | 1.82 | 1.82 | 1.42 |
Key Ratios
ROA (TTM)
5.3%
P/S (TTM)
2.61
EPS (TTM)
$0.21
Rev Growth 3Y
+131.4%
52W High
$13.70
52W Low
$4.32
$4.32
52-Week Range
$13.70
Financial Health
Free Cash Flow
-$84.0M
Net Debt
$1.2B
Cash
$42.8M
Total Debt
$1.3B
As of Sep 30, 2025
How does ALVO compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
ALVO valuation vs Biotechnology peers
P/E ratio
21.6
▲
15%
above
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
2.6
▼
80%
below
peers
(12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
—
▼
0%
below
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
ALVO profitability vs Biotechnology peers
ROE
—
▼
0%
below
peers
(-67.3%)
vs Peers
vs Industry
Top tier
Net margin
12.1%
▲
104%
above
peers
(-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
55.6%
▼
29%
below
peers
(78.6%)
vs Peers
vs Industry
Weak
ROA
5.3%
▲
111%
above
peers
(-46.7%)
vs Peers
vs Industry
Top tier
ALVO financial health vs Biotechnology peers
D/E ratio
—
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
1.4
▼
68%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
0.1
▼
87%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
ALVO fundamentals radar
ALVO
Peer median
Industry
ALVO profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
ALVO vs peers: key metrics
Top Holders
Top 5: 3.55%Vanguard Group Inc
1.43%
$14.0M
Bracebridge Capital, LLC
0.86%
$8.4M
Price (T.Rowe) Associates I…
0.46%
$4.5M
Littlejohn & Co LLC
0.42%
$4.1M
Blackrock Inc.
0.38%
$3.7M
As of Dec 31, 2025
Latest News
No related news yet